top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.0933 -0.0141 (-13.13%)
Streaming Delayed Price Updated: 10:53 AM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,345,698
Open 0.1003
Bid (Size) 0.0930 (700)
Ask (Size) 0.0945 (500)
Prev. Close 0.1074
Today's Range 0.0927 - 0.1011
52wk Range 0.0950 - 10.92
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response
Via Investor Brand Network
Dietary Fat Balance Could Influence Immune System Function, Study Finds
Via Investor Brand Network

Performance

YTD
-92.1%
-92.1%
1 Month
-42.1%
-42.1%
3 Month
-58.3%
-58.3%
6 Month
-90.7%
-90.7%
1 Year
-98.6%
-98.6%

More News

Read More
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
Top movers in Monday's after hours session ↗
Via Chartmill
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
Via Investor Brand Network
Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy
Via Investor Brand Network
Understanding Why Treatment Resistance Exists in Many Cancers
Via Investor Brand Network
AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer
Via Investor Brand Network
Topics Artificial Intelligence
Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy
Via Investor Brand Network
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
Via Investor Brand Network
Why Men Need Sexual Health Help While Undergoing Cancer Treatment
Via Investor Brand Network
FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness
Via Investor Brand Network
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
Via ACCESS Newswire
New Pill Offers Hope Against Pancreatic Cancer
Via Investor Brand Network
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
Via Investor Brand Network
Scientists Inch Closer to Developing a Lung Cancer Blood Test
Via Investor Brand Network
Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer
Via Investor Brand Network
NHS Starts Offering Immunotherapy Injection to Cancer Patients
Via Investor Brand Network
Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes
Via Investor Brand Network
Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer
Via Investor Brand Network
Study Uncovers Why the Risk of Breast Cancer Increases with Age
Via Investor Brand Network
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
Via Chartmill
Early Trial Suggests mRNA Vaccine Could Be Effective Against Pancreatic Cancer
Via Investor Brand Network

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 0.0933
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 07/29/26 10:53 AM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 668.75K
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 669K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page